In-Silico Breakthrough: EMA’s Shift from Animal Testing
The DIA Europe 2024 conference brought together leading experts to discuss groundbreaking innovations and regulatory strategies in clinical trials....
Moe Alsumidaie
BridGene Biosciences and How It Aims to Target Hard to Drug Proteins
In this interview, Dr. Ping Cao, co-founder and CEO of BridGene Biosciences, discusses targeting “hard to drug” proteins that...
EMA Needs To Release DHT Guidance Now
As digital health technologies (DHTs) increasingly permeate the landscape of clinical trials, the European Medicines Agency (EMA) faces mounting...
How CNS Trials Transform with Innovative Digital Tech
In this interview on integrating innovative digital technologies in central nervous system (CNS) trials, I engaged with Matthew Stork,...
How To Engage The FDA when Building Clinical Trial DHTs
Integrating Digital Health Technologies (DHTs) in drug development is revolutionizing clinical trials, especially with the rise of decentralized clinical...
Uncovering Challenges With New Clinical Trial Tech Implementation
In this engaging interview with Jennifer Duff, General Manager, Zelta Clinical Trials Solutions at Merative, we explore technology’s pivotal...
Unlocking New Clinical Trial Digital Health Advances
In an insightful discussion, Tom White, Chief Product Officer of Nye Health, highlights the company’s innovations in clinical trial...
Innovative Tech Solutions for Challenges in Clinical Research
In this insightful session about challenges in clinical research, I spoke with Aruna Adhikari, Head of Product and Senior...
Walmart Health Center Exit: Is It Good For Clinical Trials?
This article contains speculative content, opinions, and assumptions about the Walmart Health center that are not confirmed facts. The...
Enhancing Data Integrity: New Clinical Trial Imaging Techniques
In this interview, Jeffrey Sorenson, CEO of Yunu, outlines how his company is enhancing the precision and efficiency of...